SUMMARY: Dr. Khalili describes the natural history and pathogenesis of this parasitic disease in Iraq from his large experience in treating this disease? What percentage of the population has this disease? How is it commonly treated? Is poor sanitation the major cause of the disease? What drugs or agents are effective to treat this disease? How many get CNS complications of the disease? What are the treatments for CNS involvement? Which ones work? Can the patient or family members afford to pay for that treatment? These questions and more are Discussed with this lecture. How do you manage this disease in your country? What are the long-term complications of this disease? Is this an important Public Health Problem in Iraq and your country? What can be done to treat more people with this disease?

SUMMARY: The Authors describe the results of their retrospective clinical study from a rural Indian pediatric population treated for meningiomas neurosurgically. in the 26 children from 1-17 yrs of age studied "the ratio of males to females being 1.8:1. 23% of reported meningiomas occurred in the posterior fossa, 45% in the sphenoid and 21% in the tuberculum sellae."- Authors. Complete tumor excision was achieved in 70%. Atypical/Malignant types represented 16% of the group. Mortality was 11%. A rare study to find on this tumor in children, in study designed and completed by YNSS. Nice presentation and Discussion-JIA

SUMMARY: This project was performed at the University College of London in the Cancer Institute with the contribution of other scientists. Simple Summary: In the tumor micro environment in the brain there are immune cells which attack the tumor cell and those which protect it from attack. The authors use an agent which prevents the protecting immune cells from stopping the attacking immune cells from destroying the tumor and its foreign proteins. As a result the tumor is destroyed by the patient's own immune cells. The authors state that these counteracting immune systems extend to the human species. Thus, the drug treatment should be able to work to allow human glioblastoma cells to be destroyed. This report is about the animal studies. A very interesting new approach to glioblastoma treatment. Look for more publications on this subject.- JIA The authors' summary is: scRNa-seq and FACS analysis confirmed RG629-treatment in our mouse model depleted Tregs, likely through an Fc-gamma-receptor-mediated mechanism involving phagocytic-myeloid cells, and depleted tumour cells through enhanced clonal expansion of CD8 T cells. Conservation of Treg signatures between species suggest that the strong RG6292 treatment-effect observed in our GBM mouse model could be translated to clinic in the future and provide much-needed treatment for GBM patients.

SUMMARY: Dr. Rawandozy, Head of Neurosurgery at the Hawler Medical University in Erbil, Kurdistan, Iraq explains how the neurosurgery department was built over 20 years to become a modern Neurosurgery Center at a World Class level, starting with no department. His success is attributed to the strong local support of the community and many others making this program successful. He explains how it was done while having positions in the university and conducting a private practice. Innovative approaches to medical challenges

Summary: The lecture on the future of neurosurgery and medicine starts from a study of the vascular cause of lacunar infarctions, the cause of 20% of strokes. it is a disease we cannot diagnose with modern technology or treat now. Dr. Ausman outlines how small vessel diseases can be treated in the future using experience from the inflammatory causes of atherosclerosis and the macrophage inflammatory causes of aneurysm formation. There is a common feature of those diseases which can be treated. It is Chronic Inflammation. Chronic Inflammation is also the cause of Parkinson's disease, Alzheimer's and many other diseases in the body. It is the major disease category of the 21st century, and you will treat it, cure it, and increase longevity. Most of the diseases today will be gone by the end of the 21st century. Then you will have Space diseases and Space treatments and interplanetary Medicine and diseases. You will be living on other planets or the moon. You will find other civilizations in the universe. What is going on on earth will all change, and your lives will change . Be prepared. (Lecture-40 minutes; Discussion-15 minutes; 5/5 ranking)

SUMMARY: Over 5000 cases; Treatment Indications; Functional indications; Obsessive-Compulsive Disorders; Multi Centers in Iraq ( Basra, Erbil, Baghdad, Al-Taj Center, Saad Al Witry Neuroscience Hospital, Baghdad; Brain Tumors- all types; AVM, Nasopharyngeal CA; Pituitary Tumors; Trigeminal Neuralgia, Mesial Temporal Sclerosis; Cavernous Malformations ; Deep-seated tumors; Residual and Recurrent tumors; Tumor bed; Hypophesectomy for painful metastases; Tremors; Poor Surgical Candidates; Focal Brain Stem Tumors, Other tumors; Corpus Callosectomy; Uveal Disorders and other indications. Large Experience & Results

SUMMARY: History of Neurosurgery in Iraq: Simple Inexpensive Neuronavigtion Systems for LMIC; Ergonomic Instruments for Surgery for all; World Class Functional and Stereotactic Neurosurgery in LMIC; Guest Lecture: Functional Neurosurgery for Intractable Low Back Pain; 4 Lectures with Discussion. (JIA)

SUMMARY: Overview of Neurosurgery Training Programs in Iraq; General hospital experience; Posterior thalamic -pulvinar micro surgery; Erbil neurosurgery program; Unique Iraqi Orbital surgery; outstanding programs; LIMC neurosurgery leadership; Leadership of A. Hadi Khalili in establishing modern Iraq neurosurgery

No notes

no notes